Advertisement
The presentation will be webcast live during the conference and will beavailable to registered investors on the following site:http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=DGX&item_id=1778380and to the public on http://www.questdiagnostics.com. In addition, thearchived webcast will be available one hour following the presentation andwill remain available until April 18, 2008.
Advertisement
Quest Diagnostics is the leading provider of diagnostic testing,information and services that patients and doctors need to make betterhealthcare decisions. The company offers the broadest access to diagnostictesting services through its national network of laboratories and patientservice centers, and provides interpretive consultation through its extensivemedical and scientific staff. Quest Diagnostics is a pioneer in developinginnovative new diagnostic tests and advanced healthcare information technologysolutions that help improve patient care. Additional company information isavailable at: www.questdiagnostics.com.
The statements in this press release which are not historical facts may beforward-looking statements. Readers are cautioned not to place undue relianceon forward-looking statements, which speak only as of the date that they aremade and which reflect management's current estimates, projections,expectations or beliefs and which involve risks and uncertainties that couldcause actual results and outcomes to be materially different. Risks anduncertainties that may affect the future results of the Company include, butare not limited to, the competitive environment, changes in governmentregulations, changing relationships with customers, payers, suppliers andstrategic partners and other factors discussed in "Business" in Part I, Item1, "Risk Factors" and "Cautionary Statement for Purposes of the 'Safe Harbor'Provisions of the Private Securities Litigation Reform Act of 1995" in ItemI, Part 1A, "Legal Proceedings" in Part I, Item 3, "Management's Discussionand Analysis of Financial Condition and Results of Operations" in Part II,Item 7 and "Quantitative and Qualitative Disclosures About Market Risk" inPart II, Item 7A in the Quest Diagnostics 2007 Annual Report on Form 10-K and"Management's Discussion and Analysis of Financial Condition and Results ofOperations" and "Quantitative and Qualitative Disclosures About Market Risk"in the Company's 2008 Quarterly Reports on Form 10-Q and other itemsthroughout the Form 10-K and the Company's 2008 Quarterly Reports on Form 10-Qand Current Reports on Form 8-K.
SOURCE Quest Diagnostics Incorporated
